Dear Loyal Reader,
I want to tell you about this under-the-radar $10 stock Charles Mizrahi found.
It's a tiny company that is conquering a $33 billion Big Pharma niche.
And in last week's earnings call, the CEO disclosed that he's loading up on company stock.
Clearly, he knows something the market doesn't yet…
But Charles says it's only the beginning.
As you'll see, this is just one of Charles' top three OMEGA stocks to buy today…
The other two are just as impressive.
Take a look here — or see his full note from earlier today below.
— Travis
From: Charles Mizrahi
Sent: Monday, March 25, 2024
Subject: Tiny $10 stock has the jump on Big Pharma
Dear Loyal Reader, Right now, a tiny $10 stock is making a big move.
I'm not surprised. I've been banging the table about this company for a while.
That's because even though they're small…
They're flat out on the verge of conquering the $33 billion eye care industry.
An estimated 1 out of every 5 cataract surgeries in the U.S. already use this small company's drugs.
Heck, 8 million surgeries per year are using its drugs.
Make no mistake, the profit potential is off the charts.
As you'll see, this is just one of my top three OMEGA stocks to buy today…
The other two are just as impressive.
Here's everything you need to know.  Regards,
Charles Mizrahi
Founder, Alpha Investor
(c) 2024 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Alpha Investor. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096). Legal Notice.
The mailbox associated with this email address is not monitored, so please do not reply. However, your feedback is very important to us so if you would like to contact us with a question or comment, please click here. Remove your email from this list: Click here to Unsubscribe. | | |
Post a Comment
Post a Comment